Ulysses Neuroscience Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$542K
- Investors
-
3
Ulysses Neuroscience General Information
Description
Operator of a biotechnology company intended to research rare neurodevelopmental, psychiatric and neurodegenerative disorders. The company offers patient-centric and translational research to bridge clinical and preclinical research, enabling researchers to advance knowledge and treatment of these disorders.
Contact Information
Website
ulysses-neuro.comCorporate Office
- Pioneer Life Sciences Cherrywood, Building 10
- Cherrywood Business Park, Loughlinstown
- Dublin
- Northern Ireland, United Kingdom
Corporate Office
- Pioneer Life Sciences Cherrywood, Building 10
- Cherrywood Business Park, Loughlinstown
- Dublin
- Northern Ireland, United Kingdom
Ulysses Neuroscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 14-Mar-2024 | $542K | Completed | Generating Revenue | ||
| 1. Early Stage VC | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ulysses Neuroscience Comparisons
Industry
Financing
Details
Ulysses Neuroscience Competitors (9)
One of Ulysses Neuroscience’s 9 competitors is Iris Pharma, a Corporate Backed or Acquired company based in La Gaude, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Iris Pharma | Corporate Backed or Acquired | La Gaude, France | ||||
| Transpharmation | Corporate Backed or Acquired | London, United Kingdom | ||||
| Excelya | Private Equity-Backed | Paris, France | ||||
| Charles River Laboratories International | Formerly PE-Backed | Wilmington, MA | ||||
| Porsolt | Private Equity-Backed | Le Genest-Saint-Isle, France |
Ulysses Neuroscience Signals
Ulysses Neuroscience Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Enterprise Ireland | Growth/Expansion | Minority | ||
| Growing Capital | Venture Capital | Minority | ||
| Pioneer Group | Venture Capital | Minority |
Ulysses Neuroscience FAQs
-
When was Ulysses Neuroscience founded?
Ulysses Neuroscience was founded in 2019.
-
Where is Ulysses Neuroscience headquartered?
Ulysses Neuroscience is headquartered in Dublin, United Kingdom.
-
What is the size of Ulysses Neuroscience?
Ulysses Neuroscience has 13 total employees.
-
What industry is Ulysses Neuroscience in?
Ulysses Neuroscience’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Ulysses Neuroscience a private or public company?
Ulysses Neuroscience is a Private company.
-
What is Ulysses Neuroscience’s current revenue?
The current revenue for Ulysses Neuroscience is .
-
How much funding has Ulysses Neuroscience raised over time?
Ulysses Neuroscience has raised $542K.
-
Who are Ulysses Neuroscience’s investors?
Enterprise Ireland, Growing Capital, and Pioneer Group have invested in Ulysses Neuroscience.
-
Who are Ulysses Neuroscience’s competitors?
Iris Pharma, Transpharmation, Excelya, Charles River Laboratories International, and Porsolt are some of the 9 competitors of Ulysses Neuroscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process